Desai Manishi A, Gedde Steven J, Feuer William J, Shi Wei, Chen Philip P, Parrish Richard K
Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.
Ophthalmic Surg Lasers Imaging. 2011 May-Jun;42(3):202-8. doi: 10.3928/15428877-20110224-04.
To evaluate glaucoma surgical practice patterns among members of the American Glaucoma Society (AGS).
An anonymous web-based survey was sent to AGS members to determine their preferred surgical approach in ten clinical settings. Survey results were compared with those from 1996 and 2002.
A total of 125 (22%) AGS members responded to the survey. Mean glaucoma drainage device (GDD) usage increased from 17.5% (range: 5% to 37%; standard deviation [SD]: 10.9%) in 1996 to 50.8% (range: 15% to 76%; SD: 17.3%) in 2008, and mean trabeculectomy usage decreased from 80.8% (range: 62% to 93%; SD: 11.3%) in 1996 to 45.5% (range: 16% to 80%; SD: 17.9) in 2008. GDD was most popular in none of 8 clinical settings in 1996, and 5 of 8 clinical settings in 2008. Mitomycin C was selected as an adjunctive antifibrotic agent to trabeculectomy in 85% to 99% of cases.
Glaucoma surgical practice patterns have changed since 1996. The use of a GDD has progressively increased, and the popularity of trabeculectomy decreased between 1996 and 2008. Mitomycin C remains the most frequently selected antifibrotic agent used as an adjunct to trabeculectomy.
评估美国青光眼协会(AGS)成员的青光眼手术实践模式。
向AGS成员发送了一份基于网络的匿名调查问卷,以确定他们在十种临床情况下首选的手术方法。将调查结果与1996年和2002年的结果进行比较。
共有125名(22%)AGS成员回复了调查。青光眼引流装置(GDD)的平均使用率从1996年的17.5%(范围:5%至37%;标准差[SD]:10.9%)增加到2008年的50.8%(范围:15%至76%;SD:17.3%),小梁切除术的平均使用率从1996年的80.8%(范围:62%至93%;SD:11.3%)下降到2008年的45.5%(范围:16%至80%;SD:17.9)。1996年,GDD在8种临床情况中均不是最常用的,而在2008年,8种临床情况中有5种是最常用的。在85%至99%的病例中,丝裂霉素C被选为小梁切除术的辅助抗纤维化药物。
自1996年以来,青光眼手术实践模式发生了变化。1996年至2008年间,GDD的使用逐渐增加,小梁切除术的受欢迎程度下降。丝裂霉素C仍然是小梁切除术最常选用的辅助抗纤维化药物。